(Q33236195)

24 July 2017

title

Corrective effect on Fabry mice of yeast recombinant human alpha-galactosidase with N-linked sugar chains suitable for lysosomal delivery (English)

1 reference

24 July 2017

Yasunori Chiba

2

0 references

Kazuhiko Watabe

object named as

Kazuhiko Watabe

15

0 references

author name string

Hitoshi Sakuraba

1

1 reference

24 July 2017

Masaharu Kotani

3

1 reference

24 July 2017

Ikuo Kawashima

4

1 reference

24 July 2017

Mai Ohsawa

5

1 reference

24 July 2017

Youichi Tajima

6

1 reference

24 July 2017

Yuki Takaoka

7

1 reference

24 July 2017

Yoshifumi Jigami

8

1 reference

24 July 2017

Hiroshi Takahashi

9

1 reference

24 July 2017

Yukihiko Hirai

10

1 reference

24 July 2017

Takashi Shimada

11

1 reference

24 July 2017

Yasuhiro Hashimoto

12

1 reference

24 July 2017

Kumiko Ishii

13

1 reference

24 July 2017

Toshihide Kobayashi

14

1 reference

24 July 2017

Tomoko Fukushige

16

1 reference

24 July 2017

Tamotsu Kanzaki

17

1 reference

24 July 2017

publication date

11 March 2006

1 reference

Journal of Human Genetics

24 July 2017

published in

1 reference

24 July 2017

volume

51

1 reference

24 July 2017

issue

4

1 reference

24 July 2017

page(s)

341-352

1 reference

Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy

24 July 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10038-006-0369-6

Cytochemical and biochemical detection of intracellularly accumulated sialyl glycoconjugates in sialidosis and galactosialidosis fibroblasts with Macckia amurensis

21 January 2018

1 reference

12 December 2020

Production in yeast of alpha-galactosidase A, a lysosomal enzyme applicable to enzyme replacement therapy for Fabry disease

1 reference

12 December 2020

Cardiovascular manifestations in Fabry's disease. A high incidence of mitral valve prolapse in hemizygotes and heterozygotes

1 reference

12 December 2020

Immunofluorescence imaging diagnosis of Fabry heterozygotes using confocal laser scanning microscopy.

1 reference

12 December 2020

A female heterozygous patient with Fabry's disease with renal accumulation of trihexosylceramide detected with a monoclonal antibody

1 reference

12 December 2020

Identification of point mutations in the alpha-galactosidase A gene in classical and atypical hemizygotes with Fabry disease

1 reference

12 December 2020

Generation of one set of murine monoclonal antibodies specific for globo-series glycolipids: evidence for differential distribution of the glycolipids in rat small intestine

1 reference

12 December 2020

An Atypical Variant of Fabry's Disease in Men with Left Ventricular Hypertrophy

1 reference

12 December 2020

Production of human compatible high mannose-type (Man5GlcNAc2) sugar chains in Saccharomyces cerevisiae

1 reference

12 December 2020

Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey

1 reference

12 December 2020

Cloning and analysis of the MNN4 gene required for phosphorylation of N-linked oligosaccharides in Saccharomyces cerevisiae

1 reference

12 December 2020

Safety and efficacy of recombinant human alpha-galactosidase A replacement therapy in Fabry's disease

1 reference

12 December 2020

Establishment of immortalized Schwann cells from Sandhoff mice and corrective effect of recombinant human beta-hexosaminidase A on the accumulated GM2 ganglioside

1 reference

12 December 2020

Human alpha-galactosidase gene expression: significance of two peptide regions encoded by exons 1-2 and 6

1 reference

12 December 2020

Globotriaosylceramide accumulation in the Fabry kidney is cleared from multiple cell types after enzyme replacement therapy

1 reference

12 December 2020

A phase 1/2 clinical trial of enzyme replacement in fabry disease: pharmacokinetic, substrate clearance, and safety studies

1 reference

12 December 2020

Sex chromatin and gene action in the mammalian X-chromosome

1 reference

12 December 2020

Differential assay for lysosomal alpha-galactosidases in human tissues and its application to Fabry's disease

1 reference

12 December 2020

A biochemical and pharmacological comparison of enzyme replacement therapies for the glycolipid storage disorder Fabry disease

1 reference

12 December 2020

Analysis of mannose-6-phosphate labeled with 8-aminopyrene-1,3,6-trisulfonate by capillary electrophoresis

1 reference

12 December 2020

Infusion of alpha-galactosidase A reduces tissue globotriaosylceramide storage in patients with Fabry disease

1 reference

12 December 2020

Interaction of hepatic asialoglycoprotein receptor with asialoorosomucoid and galactolyzed lysosomal alpha-glucosidase

1 reference

12 December 2020

Long-term systemic therapy of Fabry disease in a knockout mouse by adeno-associated virus-mediated muscle-directed gene transfer

1 reference

12 December 2020

Immunofluorescence analysis of trihexosylceramide accumulated in the hearts of variant hemizygotes and heterozygotes with Fabry disease

1 reference

12 December 2020

10.1007/S10038-006-0369-6

Identifiers

DOI

1 reference

release_ppag6xpy6vg37ijdht3vt5vw2i

24 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ppag6xpy6vg37ijdht3vt5vw2i

24 November 2022

mapped directly with Wikidata item

1 reference